Multi-target Cytotoxic T Lymphocyte(MCTL®)Cancer Post-Treatment Follow-Up technology is an advanced precision medical solution integrating cancer detection and treatment. By analysing the type and quantity of tumour-specific antigens (tumour targets) in serum, we identify cancer development and determine positive targets for each individual.